Bictegravir sodium
Drug ingredientCAS 1807988-02-8
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
8 FDA-registered drug labelers
A-S Medication Solutions
Esteve Huayi Pharmaceuticals Co., Ltd
Esteve Quimica SA
Gilead Sciences, Inc.
Matrix Pharmacorp Private Limited
MSN Life Sciences Private Limited
Patheon Inc.
Takeda GmbH
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Biktarvy
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1807988-02-8
PubChem CID102593990
DTXSIDDTXSID401027938
FormulaC21H17F3N3NaO5
Mol. Weight471.4 g/mol
SMILESC1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)[O-])C(=O)NCC5=C(C=C(C=C5F)F)F.[Na+]
Data Sources
- PubChem · compound 102593990Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Bictegravir sodium (CAS 1807988-02-8) https://chemicalindependence.com/chemical/1807988-02-8/ PubChem: 102593990. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/102593990 FDA National Drug Code directory: CAS 1807988-02-8. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/